Results 21 to 30 of about 134,257 (306)

Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration [PDF]

, 2020
Background Immune checkpoint inhibitors such as nivolumab and targeted BRAF inhibitors have dramatically altered the treatment outcomes of metastatic melanoma over the past few years. Skin toxicity is the most common adverse event (AE) related to the
Maestro, Alessandra, Marcuzzi, Annalisa, Maximova, Natalia, Zanon, Davide   +3 more
core   +1 more source

Nivolumab induced vitiligo-like depigmentation in metastatic acral lentiginous melanoma

Pigment International, 2019
Melanoma is an uncommon malignancy in Indian subcontinent. Dermoscopy of cutaneous metastases of malignant melanoma has been rarely reported. Immune checkpoint inhibitors are increasingly being used for management of metastatic melanoma.
Disha Dabbas, Shekhar Neema, Niloy Pathak   +2 more
doaj   +1 more source

Cepharanthine as a Potential Novel Tumor-Regional Therapy in Treating Cutaneous Melanoma: Altering the Expression of Cathepsin B, Tumor Suppressor Genes and Autophagy-Related Proteins

Frontiers in Bioengineering and Biotechnology, 2020
The incidence of primary cutaneous melanoma continues to increase annually and is one of the most aggressive malignancies in humans and need to develop more novel non-surgical therapies.
Yufang Liu, Yang Xie, Yao Lin, Qingfang Xu, Yunfen Huang, Mengran Peng, Wei Lai, Yue Zheng   +7 more
doaj   +1 more source

Melanoma in patients with mycosis fungoides [PDF]

Vestnik Dermatologii i Venerologii, 2021
The development of both malignant neoplasms mycosis fungoides and cutaneous malignant melanoma is a rare condition; nevertheless, the literature describes both cases of the development of mycosis fungoides in patients with a primary diagnosis of ...
Arfenya E. Karamova, Anastasiya A. Vorontsova, Maryanna B. Zhilova, Lyudmila F. Znamenskaya, Rifat R. Saytburkhanov, Kseniya M. Aulova   +5 more
doaj   +1 more source

Dermatological Malignancies at a University Teaching Hospital in north-western Tanzania: A Retrospective Review of 154 Cases [PDF]

, 2012
Dermatological malignancies are among the most common form of cancers and the global incidence has been increasing at an alarming rate. A retrospective study was conducted to determine the prevalence, histopathological pattern, anatomical distribution ...
Chalya, Phillipo L., Gilyoma, Japhet M., Kahima, Kahima J., Kanumba, Emmanuel S., Masalu, Nestory, Mawala, Brian, Rambau, Peter   +6 more
core   +2 more sources

BRAF V600E Immunohistochemistry Predicts Prognosis of Patients with Cutaneous Melanoma in Thai population

Plastic and Reconstructive Surgery, Global Open, 2022
Background:. The BRAF V600E mutation in the Thai population has been identified in a considerable percentage of people with cutaneous melanoma. The objectives of this study were to determine the prevalence of this mutation in cutaneous melanomas, conduct
Jiraroch Meevassana, MD, Kullawit Anothaisatapon, MD, Surawish Subbalekha, MD, Supitcha Kamolratanakul, MD, Tippawan Siritientong, RPh, PhD, Komkrit Ruangritchankul, MD, Pornthep Pungrasami, MD, Kevin J Hamill, PhD, Apichai Angsapatt, MD, Nakarin Kitkumthorn, DDS, PhD   +9 more
doaj   +1 more source

Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment. [PDF]

, 2017
CXCR1 and CXCR2 chemokine receptors and their ligands (CXCL1/2/3/7/8) play an important role in tumor progression. Tested to date CXCR1/2 antagonists and chemokine-targeted antibodies were reported to affect malignant cells in vitro and in animal models.
Alexeev, Vitali, Allegretti, Marcello, De Pizzol, Maria, Igoucheva, Olga, Jonas, Rebecca, Kemp, Daria Marley, Larijani, Mary, Lash, Elizabeth, Pidich, Alyson, Sato, Takami, Terai, Mizue   +10 more
core   +2 more sources

Omics in Cutaneous Melanoma. [PDF]

Asian Pac J Cancer Prev
The advancement of multidimensional omics technologies holds immense promise for the future of medical treatment, particularly in addressing a wide range of human illnesses. Melanoma, which ranks among the most aggressive malignant pathologies affecting the skin, is a complex and heterogeneous oncological condition.
Spirina LV, Bogdanova VA, Chizhevskaya SY, Stepovaya EA, Nosareva OL, Zinnurova AB, Barkysheva AA.   +6 more
europepmc   +3 more sources

Worldwide Cutaneous Malignant Melanoma Incidences Analyzed by Sex, Age, and Skin Type Over Time (1955–2007): Is HPV Infection of Androgenic Hair Follicular Melanocytes a Risk Factor for Developing Melanoma Exclusively in People of European-Ancestry? [PDF]

, 2016
The cutaneous malignant melanoma (CMM) incidence has been increasing in an exponential manner in certain populations around the world for over 7 decades.
Merrill, Stephen, Subramanian, Madhan, Godar, Dianne E.   +2 more
core   +3 more sources

Exploring patterns of recurrent melanoma in Northeast Scotland to inform the introduction a digital self-examination intervention [PDF]

, 2014
Peer reviewedPublisher ...
A Korner, A Korner, AL Stanton, C Garbe, C Garbe, C Printz, F Erdmann, K Beaver, K Lee, K Moore-Dalal, M Janda, M Janda, M Weinstock, Marianne C Nicolson, MO Meyers, P Hull, Patrick Wassell, Peter Murchie, R Mackie, Rhona Auckland, S Kruijff, S Oliveria, S Ugurel, Scottish Government, Scottish Government, Scottish Intercollegiate Guidelines Network, SJ Hall, Susan Hall, TJ Dicker, U Leiter, V Terushkin, WJ Poo-Hwu   +31 more
core   +1 more source